HCPCS Code A4231: Infusion set for external insulin pump, needle type

Key takeaways

HCPCS Code A4231 describes a needle-type infusion set for an external insulin pump, but Medicare does not pay for it as a separate line item.

CMS Policy Article A52507 bundles A4231 into HCPCS Code A4224, the weekly all-inclusive supply allowance for external insulin pump maintenance, so suppliers bill A4224 instead.

Medical necessity is established through the physician’s written order and supporting medical record documentation, not a Certificate of Medical Necessity — Medicare discontinued CMNs and DME Information Forms for claims dated January 1, 2023 or later.

A4230 and A4233 are also frequently mislabeled: A4230 is the non-needle cannula infusion set, and A4233 is a replacement battery for a home blood glucose monitor, not the insulin pump itself.

Practice management software like Pabau helps DME suppliers keep physician orders, diagnosis codes, and supply records organized so A4224 claims go out clean the first time.

HCPCS Code A4231 describes a needle-type infusion set for an external insulin pump. Medicare does not pay it separately. CMS Policy Article A52507 bundles it into HCPCS Code A4224, the weekly infusion-supply allowance, and denies any separate claim as unbundling. This guide covers the official description of A4231, why it is not separately payable, and current documentation requirements. It also covers the ICD-10 pairings that support the claim and how to bill A4224 correctly.

HCPCS Code A4231: Official description and code details

HCPCS Code A4231 is a Level II HCPCS supply code that describes an infusion set for an external insulin pump, specifically the needle type. It is maintained by the Centers for Medicare & Medicaid Services, or CMS, as part of the DMEPOS (Durable Medical Equipment, Prosthetics, Orthotics, and Supplies) category.

The “needle type” designation distinguishes A4231 from A4230, the non-needle cannula infusion set for the same external insulin pump device. Both descriptors matter for documentation and clinical ordering, but neither is billed on its own. CMS Policy Article A52507 includes both in HCPCS Code A4224, the weekly all-inclusive supply allowance for external insulin pump maintenance. For a full lookup, AAPC’s code lookup tool allows filtering by the A-series and confirming descriptor accuracy.

Clinical use: When is HCPCS Code A4231 applied?

HCPCS Code A4231 describes a replacement needle-type infusion set for a patient on continuous subcutaneous insulin infusion (CSII) therapy. CSII delivers basal and bolus insulin doses via a programmable pump worn by the patient. The infusion set connects the pump reservoir to the subcutaneous tissue.

Clinical scenarios for a needle-type set include patients with Type 1 diabetes (insulin-dependent) managed on CSII. They also include select Type 2 patients whose physician has documented medical necessity for pump therapy over multiple daily injections. Patients typically replace their infusion sets every 2-3 days to reduce infection risk and maintain insulin delivery accuracy. Each replacement set is a covered supply within the weekly A4224 allowance, not a separately billable line item.

• Type 1 diabetes (E10-series ICD-10): Primary indication for CSII therapy; supplies are billed under HCPCS Code A4224
• Insulin-dependent Type 2 diabetes: Eligible when physician documents medical necessity for pump therapy
• Needle-type insertion sets specifically: Used when the patient’s pump protocol calls for a needle (steel) cannula rather than a non-needle (soft) cannula
• External pump only: A4231 does not apply to implantable pump supplies, which use separate HCPCS codes

DME suppliers should still ensure clinical documentation specifies “needle type” explicitly. This detail drives clinical ordering and audit review even though the supply bills under A4224. Using prescription management software that captures device type and supply specifications at the point of order reduces the missing details that lead to post-claim audits.

Medicare coverage and medical necessity criteria for HCPCS Code A4231

Medicare covers infusion supplies for external insulin pumps under the DMEPOS benefit when medical necessity is documented. Coverage follows the applicable Local Coverage Determination (LCD) and CMS Policy Article A52507. Because A4231 is not separately billable, this coverage applies to HCPCS Code A4224, the weekly supply allowance that includes the needle-type infusion set.

Maintaining medical necessity documentation forms that align with current CMS requirements reduces audit exposure significantly. Key coverage requirements include:

• Physician order (Standard Written Order): A written order from the treating physician specifying the external insulin pump and infusion set type (needle), on file before delivery
• Supporting medical record documentation: CMS discontinued Certificates of Medical Necessity (CMNs) and DME Information Forms (DIFs) for claims dated January 1, 2023 or later (SE22002). A CMN or DIF attached to a claim now causes rejection. Medical necessity is established through the physician’s order plus supporting notes in the patient’s medical record
• Insulin-dependent diabetes diagnosis: ICD-10 codes from the covered diagnosis list must support the claim
• Face-to-face requirement: For new DMEPOS orders, the beneficiary must have had a face-to-face clinical encounter with the ordering physician within the timeframe specified by the LCD
• LCD compliance: The claim must align with the active LCD for external infusion pumps; verify the current determination via the Medicare Coverage Database

DME suppliers managing Medicare beneficiary records have a parallel obligation. They must ensure HIPAA-compliant practice software stores and transmits physician orders and medical record documentation correctly. Missing or outdated documentation, not a missing CMN, is the leading cause of post-payment recoupment in DMEPOS audits since the CMN/DIF requirement ended.

With built-in inventory tracking, every dressing or catheter billed under these codes matches recorded stock movement.

A4231 billing status and A4224 reimbursement (2026)

HCPCS Code A4231 does not carry its own DMEPOS fee schedule rate. CMS Policy Article A52507 states that A4230 and A4231 “are not valid for claim submission to the DME MAC because they are included in code A4224.” It adds that “separate billing for any item… will be denied as unbundling.” The reimbursement that matters is the one Medicare pays under HCPCS Code A4224, the weekly all-inclusive supply allowance for the external pump (E0784). It covers cannulas, needles, dressings, and other infusion supplies, but excludes the insulin reservoir, which is billed separately under A4225.

Never submit A4230 or A4231 alongside A4224 for the same date of service. Doing so duplicates a supply that is already paid within the weekly allowance and triggers an unbundling denial. Always verify current-year A4224 rates from the CMS DMEPOS fee schedule before billing.

ICD-10 diagnosis codes for A4224 billing (includes the A4231 needle-type set)

Every claim for HCPCS Code A4224 requires a supporting ICD-10 diagnosis code that establishes medical necessity for CSII therapy. This applies whether the pump uses a needle-type (A4231) or non-needle (A4230) infusion set. Medicare’s LCD for external infusion pumps specifies covered diagnoses. The primary category is insulin-dependent diabetes mellitus (Type 1). Billing with an unsupported diagnosis code is among the top reasons for denial.

Important: The ICD-10 codes above are commonly cited in LCD crosswalk references. Always verify the active covered diagnosis list against the current CMS LCD for external infusion pumps before submitting claims. Covered diagnoses can change with annual LCD updates. Using digital intake forms that capture patient diagnosis information in a structured, codeable format streamlines this verification step at the point of order.

Billing guidelines, modifiers, and quantity limits for A4224 (includes the A4231 set)

Modifier selection and frequency compliance are where most claims involving a needle-type infusion set run into trouble. The billing rules apply to HCPCS Code A4224, not to A4231 directly. Applying the wrong modifier, attaching an obsolete CMN, or submitting above the allowed frequency triggers automatic edits.

Required modifiers

The KX modifier is the most critical for routine A4224 Medicare billing. Submitting without KX when documentation exists leaves money on the table. Submitting KX when documentation is incomplete exposes the supplier to recoupment. Verify documentation status before every claim submission using a workflow that flags incomplete physician-order or medical-record files before the billing queue.

Quantity limits

Medicare applies frequency limits to A4224 through the applicable LCD, since it is billed as a weekly all-inclusive allowance rather than a per-unit supply. The number of weeks billed is based on the patient’s pump usage protocol and documented medical necessity. The specific allowed frequency must be verified against the current active LCD, as CMS adjusts these periodically. Billing more weeks than the LCD allows, without documentation of higher clinical need, results in automatic claim edits and denial of excess units.

Tracking billed weeks per beneficiary requires a system that can flag when a patient approaches their allowed frequency within a billing period. Practice management software like Pabau keeps physician orders, diagnosis codes, and supply records organized in one place. That helps prevent inadvertent overbilling, which is both a denial risk and a compliance concern under Medicare’s DMEPOS rules. Ensure all HIPAA-compliant billing documentation is retained per the applicable record retention schedule.

A4231 vs related insulin pump supply codes

The A4225, A4230-A4233 code range covers infusion sets and related supplies for external insulin pumps. Selecting the wrong code from this cluster is a frequent billing error. For the syringe code in this range, see A4232 for its own billing status.

A4230 and A4231 are the most commonly confused pair, and both share the same billing status: neither is separately payable. CMS Policy Article A52507 bundles both into HCPCS Code A4224. Clinically, the distinction is still worth documenting. A needle-type set (A4231) uses a steel needle that stays in the subcutaneous tissue throughout the wear period. A non-needle set (A4230) uses a soft cannula inserted via a retractable needle guide. The guide then withdraws, leaving only the flexible cannula in place. A4225, the insulin reservoir cartridge, is the one code in this range billed separately from A4224 rather than bundled into it. A4233 is unrelated to the pump entirely: it is a battery for the patient’s home blood glucose monitor.

How to bill for the A4231 needle-type set: Step-by-step for DME suppliers

HCPCS Code A4231 is never billed on its own. Here is the end-to-end billing process for DME suppliers submitting the weekly A4224 claim that includes a needle-type infusion set. Using medical practice management software that integrates with your billing queue makes each step faster and auditable.

1. Obtain a written physician order (Standard Written Order) specifying the external insulin pump and infusion set type (needle type). The order must precede delivery of the supply.
2. Confirm supporting medical record documentation. CMS discontinued Certificates of Medical Necessity and DME Information Forms for claims dated January 1, 2023 or later (SE22002); do not collect or attach a CMN. Instead confirm the physician’s order and the clinical notes in the patient’s chart establish medical necessity.
3. Confirm the ICD-10 diagnosis code matches a covered diagnosis in the current LCD. Cross-check against the active covered diagnosis list before proceeding.
4. Verify the beneficiary’s competitive bidding status. If the delivery address falls within a competitive bidding area for insulin pump supplies, confirm your contract status before submission.
5. Determine the correct modifier for the A4224 claim. Attach KX if documentation confirms LCD compliance. Attach GA if an Advance Beneficiary Notice (ABN) is on file. Use GZ if the item does not meet coverage criteria and no ABN was obtained, to secure an expected denial.
6. Bill HCPCS Code A4224 as the weekly all-inclusive supply allowance. Do not submit A4230 or A4231 as a separate line item on the same claim; CMS Policy Article A52507 denies this as unbundling.
7. Submit the claim on a CMS-1500 form (or electronic equivalent) with HCPCS Code A4224, modifier, billed weeks, ICD-10 code, and supplier NPI.
8. Track the remittance advice. Review the ERA for denial codes. Common denial reasons include CO-4 (modifier mismatch), CO-50 (not medically necessary), CO-119 (quantity exceeds limit), and B20 with remark M115 (non-contract supplier billing in a competitive bidding area).

That reduces manual transcription errors that generate step 7 and 8 failures.

Common billing errors and how to avoid them

HCPCS Code A4231 has a predictable denial pattern, and the top error is billing it in the first place. The same errors appear repeatedly across DMEPOS audits and AAPC member forum discussions. Addressing each one in your pre-submission workflow eliminates the majority of rejections.

• Billing A4230 or A4231 as a separate line item: CMS Policy Article A52507 bundles both into A4224. Submitting either on its own, regardless of documentation quality, is denied as unbundling. Bill A4224 and keep the needle-type or non-needle designation in the medical record for clinical and audit purposes only.
• Missing KX modifier on the A4224 claim: Submitting A4224 to Medicare without KX when valid documentation exists generates an automatic CO-4 denial. The fix is a documentation-complete checklist that gates modifier assignment at claim creation, not after denial receipt.
• Attaching a Certificate of Medical Necessity: CMS discontinued CMNs and DME Information Forms for claims dated January 1, 2023 or later. A CMN or DIF attached to a claim today causes rejection rather than support. Confirm the physician’s order and medical record documentation instead.
• Unsupported ICD-10 pairing: Using a non-covered ICD-10 code (for example, a Type 2 diabetes code without documented insulin-dependent status) triggers a CO-50 (not medically necessary) denial. Cross-reference the diagnosis code against the covered list in the LCD before submission on every claim, not just new patients.
• Exceeding the LCD’s allowed frequency without justification: Billing more weeks of A4224 than the LCD allows, without documented clinical justification for higher utilization, generates a CO-119 denial. Track billed weeks per beneficiary and flag claims that approach the limit before submission.
• Billing in a competitive bidding area without a contract: Non-contract suppliers who bill Medicare for insulin pump supplies in a CBA receive a B20 denial with remark code M115. They also face potential compliance action. Verify CBA status by ZIP code before accepting any order. Using patient data security tools that log order intake details with location data helps flag CBA status at the point of order entry.

Related HCPCS codes

• HCPCS code A0427 — ALS Emergency Ambulance Transport
• HCPCS Code A4233 — Alkaline battery for home blood glucose monitor
• HCPCS code A4234 — J-cell glucose monitor battery

How Pabau supports accurate DME billing documentation

Many DME suppliers still track physician orders, diagnosis codes, and supply specifications for insulin pump patients across separate spreadsheets and paper charts. That split makes it easy to miss the detail that supports a clean A4224 claim. Examples include whether the pump uses a needle or non-needle infusion set, or whether the physician’s order was signed before delivery. Whether the order originates from a general practice or a metabolic health practice managing insulin-dependent patients, the same missing detail causes the same claim denial.

Practice management software like Pabau keeps the physician’s order, diagnosis codes, and supply details from intake in one patient record. Billing staff can confirm documentation is complete before a claim goes out, instead of finding a missing item after a denial arrives.

The result is fewer claims returned for missing modifiers or unsupported diagnoses, and less time spent reconstructing documentation after the fact.

Keep DME billing documentation organized

Pabau’s practice management software keeps physician orders, diagnosis codes, and supply records together in one patient file, helping DME suppliers and practice billing teams confirm documentation is complete before submitting a claim.

Book a demo

Conclusion

HCPCS Code A4231 is straightforward to describe but easy to bill incorrectly, because Medicare never pays it as its own line item. CMS Policy Article A52507 bundles it, along with A4230, into HCPCS Code A4224. The CMN requirement that older billing guides still reference ended for dates of service on or after January 1, 2023.

Getting the claim right now comes down to billing A4224 and attaching the KX modifier when the physician’s order and medical record documentation support it. Pair the claim with a covered ICD-10 code, and never itemize A4230 or A4231 separately. Book a demo to see how Pabau keeps that documentation organized for DME suppliers and practice billing teams.

Continue your research

Billing a different DME or diagnostic code? A4641 covers the documentation habits that keep radiopharmaceutical claims from denial.

Managing multi-payer billing workflows? Practice management vs EMR explains how integrated practice management helps billing teams maintain compliant records across Medicare and secondary payers.

Coding a complex surgical claim? 11005 walks through the bundling rules and modifiers a debridement claim needs.

Curious about skin lesion destruction billing? 17264 breaks down the size-based CPT tiers coders often mix up.

Frequently asked questions